Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2002
06/27/2002US20020082417 Compound for use in the treatment of vision defects and chronic obstructive pulmonary diseases
06/27/2002US20020082242 Compositions and methods of double-targeting virus infections and cancer cells
06/27/2002US20020081589 Gene expression monitoring using universal arrays
06/26/2002EP1216257A1 Compounds for the treatment of ischemia
06/26/2002CN1355713A Releasable bond and composition containing said bond
06/26/2002CN1086704C Compound having antihypertensive, cardioprotective, anti-ischemic and ant ilipolytic functions
06/25/2002US6410702 Oligonucleotide; for use in the human therapeutics and diagnostics
06/25/2002US6410675 Functionalized silicon compounds and methods for their synthesis and use
06/25/2002US6410225 Purification of oligomers
06/20/2002WO2002048331A2 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars
06/20/2002WO2002048166A1 Indolocarbazole anticancer agents and methods of using them
06/20/2002WO2002048165A2 Antiviral agents for treatment of flaviviridae infections
06/20/2002US20020076703 A substrate; a first electrode and a second electrode spaced apart from each other on the substrate and a block copolymer string (having width of less than 50 nm) positioned on the substrate between two electrodes
06/20/2002CA2429352A1 Antiviral agents for treatment of flaviviridae infections
06/19/2002EP1214331A2 2-azapurine compounds and their use
06/19/2002EP0885233B1 Terpyridine-platinum(ii) complexes
06/18/2002US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
06/18/2002US6407078 AZT derivatives exhibiting spermicidal and anti-viral activity
06/18/2002US6407076 Adenosine analogues and related method of treatment
06/18/2002US6406854 Polymer separation system using electrophoresis of polynucleotide pairs, detection of signals of polynucleotide pairs and regions in polymer separation
06/18/2002US6406844 Screening an array for affinity with a receptor, two different molecules are polypeptides, amino acid sequences
06/13/2002WO2002021098A3 A method for identifying polymorphisms
06/13/2002US20020072597 Compound for use in the treatment of; sepsis, urogential, psychological, nervous system, respiratory, inflammatory, skin vascular and arthritic; wound healing agents
06/12/2002EP1212457A2 Uv excitable fluorescent energy transfer dyes
06/12/2002EP1212416A2 Nucleic acid based modulators of gene expression
06/12/2002EP1212339A1 2'-o-acetamido modified monomers and oligomers
06/12/2002EP1212338A2 Nucleoside derivatives with photo-unstable protective groups
06/12/2002EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
06/12/2002EP0941370B1 Stabilized aqueous nucleoside triphosphate solution
06/12/2002EP0876390B1 Reusable solid support for oligonucleotide synthesis, process for production thereof and process for use thereof
06/12/2002EP0734391B1 Pna-dna-pna chimeric macromolecules
06/11/2002US6403957 Nucleic acid reading and analysis system
06/11/2002US6403786 Compounds used to label, detect and sequence nucleic acids
06/11/2002US6403779 Dissolving nucleoside in aprotic solvent, cooling, treating with base, warming mixture, cooling, reacting with reactive ester to effect alkylation
06/11/2002US6403568 For therapy of acquired immunodeficiency syndrome (aids)
06/11/2002US6403567 To stimulate mammalian coronary vasodilatation and for imaging the heart; regadenoson
06/11/2002US6403566 Conformationally locked; antiviral, anticancer, stability to cellular nucleases and strong binding affinity to nucleic acid targets.
06/11/2002US6403321 Positioning polymer string between electrodes; applying voltage; semiconductor chips
06/11/2002US6403320 Support bound probes and methods of analysis using the same
06/11/2002CA2122627C Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
06/11/2002CA2057441C Synthetic conversion of bryostatin 2 into bryostatin 1
06/06/2002WO2002044425A2 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
06/06/2002WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels
06/06/2002WO2002044196A1 Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of rna
06/06/2002WO2002044195A2 Method for base sequencing and biologically active nucleic acids
06/06/2002WO2002044194A1 L-nucleic acid derivatives and processes for the synthesis thereof
06/06/2002US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity
06/06/2002US20020068331 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
06/06/2002CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels
06/05/2002EP1211259A1 Antibiotic caprazamycins and process for producing the same
06/05/2002EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE
06/05/2002EP1169309A4 Propynyl uracils
06/05/2002EP1109817B1 Phosphohalohydrins, method for making same and uses
06/05/2002EP0642516B1 Macrocyclic immunomodulators
06/04/2002US6399754 Sugar modified oligonucleotides
06/04/2002US6399589 Viricides; antitumor agents
06/04/2002CA2024824C 13-alkyl-23-imino derivatives of ll-f28249 compounds and their use as endo- and ectoparasiticidal insecticidal, acaricidal and nematocidal agents
05/2002
05/30/2002WO2002028875A3 Improved synthesis of purine locked nucleic acid analogues
05/30/2002WO2002020538A3 Stavudine polymorphic form 1 process
05/30/2002WO2001091737A3 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides
05/30/2002WO2001087913A3 Method for treating retinal degeneration with purinergic receptor agonists
05/30/2002WO2001087235A3 Method for producing[18f]fluoride ion
05/30/2002US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
05/30/2002US20020064782 Fluorescent nucleotides
05/29/2002EP1209166A1 Novel a-500359 derivatives
05/29/2002EP1208234A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
05/29/2002EP1208109A2 Nucleoside analogues
05/29/2002EP1207890A2 Antiviral prodrugs
05/29/2002EP1070076A4 Chiral separations of pyrimidines
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002US6395716 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
05/28/2002US6395713 Cationic lipidcationic lipid
05/28/2002US6395492 Derivatized oligonucleotides having improved uptake and other properties
05/28/2002US6395491 Coding and storing information on substrate; code biopolymer sequence, attach to substrate, recover information by replication of biopolymer sequence
05/23/2002WO2002040701A2 Energy transfer labels with mechanically linked fluorophores
05/23/2002WO2001072294A3 Method of treating hepatitis delta viral infection
05/23/2002US20020062018 Process for the preparation of 2'- fluoro-5-methyl-beta-l-arabino- furanosyluridine
05/23/2002US20020061898 Inhibitors of nucleoside metabolism
05/23/2002US20020061896 Imidazopyrimidine nucleoside analogues with anti-HIV activity
05/22/2002CN1350542A Xylo-LNA analogues
05/21/2002US6392089 Photoreleasable protecting groups on alcohols, phosphates and diacids and the use thereof
05/21/2002US6392032 Compound for use as a modulator of plant propagation; for use as herbicide; for use as antitumor agent
05/21/2002US6391859 [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
05/21/2002US6390821 Phosphorylation
05/16/2002WO2002038579A1 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
05/16/2002WO2002038578A1 Modified nucleosides and nucleotides and use thereof
05/16/2002US20020058803 Preparing preferential compound; incubate sugar with activating agent, couple activated sugar with preferential compound, recover compound
05/16/2002US20020058641 Selective, functional agonists of the human adenosine A2a receptor and may be used as antiinflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
05/16/2002US20020058635 Purine L-nucleosides, analogs and uses thereof
05/16/2002US20020058275 Adjustment of defective fitting nucleotide sequences; obtain nucleotide sequence samples, incubate dimer binding protein, monitor sample for bound complexes
05/16/2002US20020058272 Luminescent marker; for use in the detection of preferential nucleotide sequences
05/16/2002US20020058263 Generalized target-binding e-tag probe compositions
05/15/2002EP1204415A2 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
05/15/2002EP1071812A4 A method, reagent solution and kits for dna sequencing
05/15/2002CN1349541A L-ribo-LNA analogues
05/15/2002CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives
05/14/2002US6387889 Reducing ocular tension
05/14/2002US6387876 Covalent polar lipid-conjugates with biologically active compounds for use in salves
05/10/2002WO2002036832A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
05/10/2002WO2002036601A2 Phase transfer catalyzed glycosidation of an indolocarbazole